Loading
AP
Ariad Pharmaceuticals Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 03 Feb 2016.
Ariad Pharmaceuticals Inc: what insiders have been doing
Ariad Pharmaceuticals Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for Ariad Pharmaceuticals Inc. The previous disclosure was published on 9 February 2016.
Looking back to 2016, when coverage begins, insiders filed 1 purchase and 8 sales.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
33
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
8 ops. · all time
Financial data
as of FY 2015FY ended December 2015 · cache
Income statement
Revenue106M
Net income-206.2M-194.6% margin
Last declaration on 9 February 2016
Declarations33 total
12,500 sharesCommon StockSEC:0001127602-16-040253:0
29,333 sharesCommon StockSEC:0001127602-16-039302:0
1,466 sharesCommon StockSEC:0001127602-16-039302:1
14,667 sharesCommon StockSEC:0001127602-16-039302:2
29,333 sharesCommon StockSEC:0001127602-16-039303:0
14,667 sharesCommon StockSEC:0001127602-16-039303:1
29,333 sharesCommon StockSEC:0001127602-16-039305:0
14,667 sharesCommon StockSEC:0001127602-16-039305:1
29,333 sharesCommon StockSEC:0001127602-16-039308:0
16,133 sharesCommon StockSEC:0001127602-16-039308:1
29,333 sharesCommon StockSEC:0001127602-16-039311:0
14,667 sharesCommon StockSEC:0001127602-16-039321:1
12,500 sharesCommon StockSEC:0001127602-16-039325:0
12,500 sharesCommon StockSEC:0001127602-16-039329:0
12,500 sharesCommon StockSEC:0001127602-16-039334:0
23,902 sharesCommon StockSEC:0001127602-16-039337:0
12,500 sharesCommon StockSEC:0001127602-16-039344:0
12,500 sharesCommon StockSEC:0001127602-16-039345:0
12,500 sharesCommon StockSEC:0001127602-16-039346:0
12,500 sharesCommon StockSEC:0001127602-16-039358:0
61,099 sharesCommon StockSEC:0001127602-16-039363:0
Canonical exit: 1 May 2016 (T+90)
29,333 sharesCommon StockSEC:0001127602-16-039317:0
14,667 sharesCommon StockSEC:0001127602-16-039317:1
29,333 sharesCommon StockSEC:0001127602-16-039321:0
14,667 sharesCommon StockSEC:0001127602-16-039311:1
25 of 33 declarations
About Ariad Pharmaceuticals Inc
Ariad Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for cancer. It specializes in targeted therapies to improve patient outcomes.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
